DE:2US / NextCure, Inc. - Net Long/Short Value

NextCure, Inc.
DE ˙ MUN
4,73 € 0,00 (0,00%)
2025-09-11
AKTIENPREIS
DE:2US / NextCure, Inc. - Net Long/Short Value
Auf dieser Seite finden Sie die Netto-Long/Short-Bewertungen für jede institutionelle Beteiligung, die über die 13F- oder NPORT-Berichte gemeldet wurde. Um den Netto-Long/Short-Wert zu berechnen, addieren wir den Aktienwert zum Wert der Call-Option und ziehen den Wert der Put-Option ab. Fonds, die geliehene Short-Positionen melden, weisen den Aktienwert als negativ aus. Netto-Long-Positionen haben positive Zahlen in der Netto-Long/Short-Spalte, und Netto-Short-Positionen haben negative Werte in dieser Spalte.
Besitzer Eigenkapitalwert
($1000)
Call Wert
($1000)
Put Wert
($1000)
Net Long/Short
($1000)
Woodline Partners LP
Vanguard Capital Management Llc
BlackRock, Inc.
Bnp Paribas Arbitrage, Sa
Jpmorgan Chase & Co
Affinity Asset Advisors, LLC
Renaissance Technologies Llc
Barclays Plc
Morgan Stanley
Pfizer Inc
Verdad Advisers, LP
Ikarian Capital, LLC
Exome Asset Management LLC
Vanguard Group Inc
Boothbay Fund Management, Llc
Acadian Asset Management Llc
Citadel Advisors Llc
Geode Capital Management, Llc
UBS Group AG
Squadron Capital Management LLC
Silverarc Capital Management, Llc
Opaleye Management Inc.
Sofinnova Investments, Inc.
Vanguard Fiduciary Trust Co
AWM Investment Company, Inc.
Cardiff Park Advisors, Llc
Citigroup Inc
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
US:NXTC 2,95 $
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista